$JVABearishMed

Coffee Holding Company Reports Second Quarter Results.

Coffee Holding Co. (Nasdaq: JVA) reported fiscal Q2 ended April 30, 2026. Net sales fell 5.1% to $22.13M from $23.32M, driven by a rapid decline in green coffee prices. Cost of sales was $18.64M (84.2% of sales). Gross profit dropped to $3.49M; net income was $262,489 ($0.05/share) vs $644,055 ($0.11) a year earlier.

8/10
8/10
Med
Bearish
after-hours / same-day earnings release (June 12, 2026)
risk-off for small-cap coffee/commodity-exposed roasters due to margin and volume pressure

Earnings print highlights margin pressure and demand softness tied to a rapid decline in green coffee prices, with management citing inventory reduction plans.

Coffee Holding reported Q2 results for the quarter ended April 30, 2026, with net sales down 5.1% and net income down to $262k.

Near-term downside bias as investors may reprice earnings power given lower sales volumes and gross margin compression; watch for stabilization if coffee prices firm.

Background

Coffee Holding Co., Inc. (JVA) released operating results for the fiscal quarter ended April 30, 2026, attributing performance to a steep decline in green coffee prices starting late January.

Why it matters

Net sales fell 5.1% year over year and net income dropped to $262,489, with gross margin slipping to 15.8% from 16.0%. Management linked the decline to lower realizable prices for green coffee inventory and a customer “wait and see” approach, while noting increased promotions and selective cost reductions.

Market relevance

Traders can use the earnings datapoints and management’s commodity linkage to reassess near-term earnings sensitivity to green coffee price moves and hedging outcomes.

Market effects

Reinforces that integrated coffee roasters/dealers are highly sensitive to green coffee price swings, with promotional activity and margin compression when commodity prices fall.

Limited direct regional spillover; impacts primarily US consumer/wholesale coffee supply chain participants.

Commodity-driven read-through to global green coffee pricing and hedging effectiveness for coffee importers/roasters.

Alternative perspectives

Management suggests a “silver lining” from newly awarded business and expects improved margins on lower input costs, which could offset some near-term volume weakness.

Inventory reduction could improve working capital and reduce future carrying costs; also, cost of sales as a % of sales rose slightly despite lower volume, implying mix/packaging dynamics worth monitoring.

Key entities

  • Coffee Holding Co., Inc.

    Integrated wholesale coffee roaster and dealer; reported Q2 results and commodity-driven margin/volume impacts.

  • Andrew Gordon

    President and CEO who attributed results to the rapid decline in green coffee prices and discussed inventory reduction and new business.

Related articles

$JVAMed

COFFEE HOLDING CO INC (JVA): Results of Operations and Financial Condition

COFFEE HOLDING CO INC (JVA) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 Coffee Holding Company Reports Second Quarter Results. STATEN ISLAND, New York – June 12, 2026. Coffee Holding Co., Inc. (Nasdaq: JVA) (the “Company,” “our” or “we”) announced its operating results for the fiscal quarter ended April 30, 2

$AZNHighAI 8/10

AstraZeneca Plunges After New Heart Disease Drug Fails Trial

AstraZeneca said its heart disease drug Wainua failed to beat placebo in a clinical trial for transthyretin-mediated amyloid cardiomyopathy (ATTR-CM), according to AstraZeneca and Ionis Pharmaceuticals. AstraZeneca shares fell up to 10.6% in London and 5.7% on the NYSE. Rival ATTR-CM drug makers Pfizer, BridgeBio, and Alnylam initially moved higher or lower.

$WDFCMedAI 8/10

WD-40 Q3 Earnings Call Highlights

WD-40 Company (NASDAQ:WDFC) reported Q3 gross margin of 56.6% and non-GAAP net income of $31.5 million, with non-GAAP EPS of $2.33. EMEA sales rose 17% to $66.6 million and Asia-Pacific sales rose 24% to $27.3 million. FY2026 constant-currency net sales guidance is $652 million to $667 million. The board authorized a $100 million share repurchase program.

$RXSTMedAI 8/10

RxSight Q2 Sales Sink 20% as Alcon Deal Bolsters 2026 Outlook

RxSight (NASDAQ:RXST) reported Q2 sales of 11 Light Delivery Devices (LDDs) and one LDD rental, lowering sales 20% and leaving an installed base of 1,166 units. Cash, cash equivalents and short-term investments were about $209M. It revised 2026 revenue to $140M-$160M, including $110M-$120M RxSight sales and $30M-$40M Alcon collaboration revenue, and raised gross margin outlook to 73%-75%.

$WDFCHighAI 9/10

Why WD-40 Stock Popped Today

WD-40 (WDFC) shares rose after the company reported fiscal 2026 Q3 net sales up 24% to $195 million and adjusted EPS of $2.33, above the $1.56 estimate. Operating income increased 47% to $40.3 million. WD-40 raised full-year guidance to net sales of $675-$690 million and adjusted EPS of $6.05-$6.35.